Furthermore, the enrichment of a CCR7 + DC signature (mregDC) has been linked to improved survival in lung cancer, cutaneous melanoma, breast, and colorectal cancer by analyzing 4,045 human solid tumor transcriptomes from the TCGA73. This evidence concerns the gene CCR7 and cutaneous melanoma.